The Changing Landscape of Fertility Diagnosis and Treatment

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Reproductive Medicine & Andrology".

Deadline for manuscript submissions: 20 June 2024 | Viewed by 588

Special Issue Editors


E-Mail Website
Guest Editor
1. Division of Reproductive Endocrinology & Infertility, University of Vermont Larner College of Medicine, 89 Beaumont Ave, Burlington, VT 05405, USA
2. Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06510, USA
Interests: granulosa cell function; ovarian biology; infertility; steroid pathway; long noncoding RNAs; microRNAs
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine, 333 Cedar St, New Haven, CT 06510, USA
Interests: reproductive aging; AMH; racial disparities in IVF; fertility preservation; in vitro fertilization; assisted reproductive technology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, the field of reproductive medicine has witnessed a profound transformation, propelled by a convergence of scientific breakthroughs, societal shifts, and evolving cultural norms. This dynamic landscape has ushered in an era of unprecedented possibilities and challenges in the realm of fertility diagnosis and treatment. This Special Issue seeks to unravel the multifaceted perspectives of this evolving landscape, illuminating key trends and critical issues that are reshaping the way we perceive, diagnose, and address fertility concerns. We will bring together a diverse array of perspectives encompassing the latest research, clinical insights, and delve into the scientific advancements aimed at preserving reproductive potential and ensuring healthier outcomes for women and couples navigating the complex terrain of infertility.

Dr. Amanda N. Kallen
Dr. David B. Seifer
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • infertility
  • reproductive aging
  • in vitro fertilization
  • fertility
  • ovarian aging
  • ovary
  • uterus
  • sperm
  • tubal factor infertility
  • male factor infertility
  • biomarkers

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

12 pages, 608 KiB  
Review
Moving toward Narrowing the United States Gap in Assisted Reproductive Technology (ART) Racial and Ethnic Disparities in the Next Decade
by Jasmin Mahabamunuge and David B. Seifer
J. Clin. Med. 2024, 13(8), 2224; https://doi.org/10.3390/jcm13082224 - 11 Apr 2024
Viewed by 389
Abstract
The Disparities in Assisted Reproductive Technology (DART) hypothesis, initially described in 2013 and further modified in 2022, is a conceptual framework to examine the scope and depth of underlying contributing factors to the differences in access and treatment outcomes for racial and ethnic [...] Read more.
The Disparities in Assisted Reproductive Technology (DART) hypothesis, initially described in 2013 and further modified in 2022, is a conceptual framework to examine the scope and depth of underlying contributing factors to the differences in access and treatment outcomes for racial and ethnic minorities undergoing ART in the United States. In 2009, the World Health Organization defined infertility as a disease of the reproductive system, thus recognizing it as a medical problem warranting treatment. Now, infertility care is largely recognized as a human right. However, disparities in Reproductive Endocrinology and Infertility (REI) care in the US persist today. While several studies and review articles have suggested possible solutions to racial and ethnic disparities in access and outcomes in ART, few have accounted for and addressed the multiple complex factors contributing to these disparities on a systemic level. This review aims to acknowledge and address the myriad of contributing factors through the DART hypothesis which converge in racial/ethnic disparities in ART and considers possible solutions to effect large scale societal change by narrowing these gaps within the next decade. Full article
(This article belongs to the Special Issue The Changing Landscape of Fertility Diagnosis and Treatment)
Show Figures

Figure 1

Back to TopTop